DMPA and HIV: do we need a trial?
The relationship between the use of progestin-only injectable contraceptives and the risk of HIV acquisition remains unclear. In this Editorial, the authors discuss the state of knowledge, current research, and the conflicting views of experts. One key issue is whether or not a trial- one designed specifically to examine this relationship- is warranted. The authors present the practical problems with undertaking such a study, and call for much greater discussion on the topic.
Access the full article at: http://www.contraceptionjournal.org/article/S0010-7824%2814%2900611-8/fulltext.